Streetbeat News

TGEN

Tecogen Inc

https://www.tecogen.com/

CEO

Benjamin Locke

Employees

Industry

Steam and Air-Conditioning Supply

Open

2.23

Mkt cap

64M

Volume

206K

High

2.59

P/E Ratio

-11.68

52-wk high

3.40

Low

2.02

Div yield

N/A

52-wk low

0.58

The article highlights recent insider transactions for penny stocks, including Bespoke Extracts, Thunder Mountain Gold, Tecogen, and Perfect Moment. Insider buying can indicate confidence in the company's prospects.

Portfolio Pulse from Avi Kapoor

July 16, 2024 | 11:29 am

The article discusses recent insider transactions for three penny stocks: Comstock Inc. (NYSE: LODE), Veru Inc. (NASDAQ: VERU), and Tecogen Inc. (OTC: TGEN). Insiders buying shares can indicate confidence in the company's prospects.

Portfolio Pulse from Avi Kapoor

May 29, 2024 | 12:34 pm

Insiders are aggressively buying shares of Tecogen Inc., Standard BioTools Inc., and OPKO Health Inc. despite recent financial challenges. This insider activity may indicate confidence in the companies' future prospects.

Portfolio Pulse from Avi Kapoor

May 20, 2024 | 12:36 pm

Insiders at Expensify, New Peoples Bankshares, and Tecogen have recently made significant purchases of their companies' stocks, indicating potential confidence in their respective companies' futures. Expensify and Tecogen are both expected to announce their first-quarter financial results soon, which could be a factor influencing these insider transactions.

Portfolio Pulse from Avi Kapoor

May 06, 2024 | 11:11 am

Insiders at Tecogen Inc., Bespoke Extracts Inc., and GlucoTrack Inc. have recently made significant purchases of their companies' stocks, signaling potential confidence in their respective companies' futures. Tecogen is poised to release its Q1 financial results, Bespoke Extracts has seen a 22% stock decline over six months, and GlucoTrack announced the closing of a private placement.

Portfolio Pulse from Avi Kapoor

April 25, 2024 | 1:03 pm

Insiders at Tecogen Inc. and Brightcove Inc. have recently made significant stock purchases, signaling potential confidence in their companies' futures. Tecogen Director John Hatsopoulos bought 1,000 shares at $0.70 each, following a report of a quarterly net loss of $1.8 million. Brightcove's 10% owner Jonathan Brolin acquired 15,175 shares at $1.75 each, shortly after the appointment of John Wagner as CFO. These transactions occur amidst a broader market downturn, with the Dow Jones dropping by 475 points.

Portfolio Pulse from Avi Kapoor

April 15, 2024 | 12:59 pm

Insiders at Palatin Technologies, Tecogen, and Augusta Gold have recently made significant stock purchases, signaling potential confidence in their companies' futures. Tecogen's Director acquired shares at $0.70 each, following a reported revenue of $5.9 million and a net loss for the last quarter of 2023. Augusta Gold's Executive Chairman bought shares at $0.81 each after the company named an interim CFO. Palatin Technologies saw a Director purchase shares at $2.12 each, subsequent to announcing promising results from a Phase 3 trial for a dry eye disease treatment.

Portfolio Pulse from Avi Kapoor

April 12, 2024 | 12:36 pm

Insiders at Tecogen, Flora Growth, and RENN Fund have recently made significant purchases of their companies' stocks, indicating potential confidence in their respective companies' futures. Tecogen's Director acquired shares at a low price following a reported net loss, while Flora Growth's CEO made a $1M purchase amid a new public offering. RENN Fund's CEO bought shares after a 6-month 8% decline in stock price.

Portfolio Pulse from Avi Kapoor

April 10, 2024 | 12:35 pm

Insiders at Citizens, Tecogen, and Silo Pharma have recently made notable purchases of their companies' stocks, signaling potential confidence in their respective companies' futures. Citizens' director bought shares at $2.14 each, Tecogen's director at $0.70 each, and Silo Pharma's CEO at $1.99 each. These transactions come alongside various company developments, including executive appointments and financial results.

Portfolio Pulse from Avi Kapoor

April 09, 2024 | 1:03 pm

Insiders at CalciMedica, Tecogen, and RENN Fund have recently made significant stock purchases. CalciMedica's Chief Business Officer acquired shares at an average price of $3.90, following a Q4 loss report. Tecogen's Director bought shares at $0.70 each after announcing Q4 revenues and a net loss. RENN Fund's President and CEO purchased shares at $1.56 each, with the stock gaining 5% over the past month. These transactions may indicate insider confidence in the companies' prospects.

Portfolio Pulse from Avi Kapoor

April 03, 2024 | 1:13 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.